Items where Research Centre is "College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology" and Year is 2023

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Authors | Item Type | No Grouping
Jump to: A | B | C | E | F | G | H | I | J | K | L | M | N | O | P | R | S | V | W | Z
Number of items: 75.

A

Aletaha, D. et al. (2023) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases, 82(6), pp. 773-787. (doi: 10.1136/ard-2022-222784) (PMID:35953263)

B

Barnes, E. et al. (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29(7), pp. 1760-1774. (doi: 10.1038/s41591-023-02414-4) (PMID:37414897) (PMCID:PMC10353927)

Blanke, J., Pahnke, K., Bompard, M. and Longman, J. (2023) The impact of volcanic ash deposition and the Storegga Slide on organic carbon preservation processes in marine sediments near Iceland. Marine Geology, 463, 107120. (doi: 10.1016/j.margeo.2023.107120)

Briggs, E. M., Marques, C. A. , Oldrieve, G. R., Hu, J., Otto, T. D. and Matthews, K. R. (2023) Profiling the bloodstream form and procyclic form Trypanosoma brucei cell cycle using single cell transcriptomics. eLife, 12, e86325. (doi: 10.7554/eLife.86325) (PMID:37166108) (PMCID:PMC10212563)

Britton, C. , Laing, R. , McNeilly, T. N., Perez, M. G. , Otto, T. D. , Hildersley, K. A., Maizels, R. M. , Devaney, E. and Gillan, V. (2023) New technologies to study helminth development and host-parasite interactions. International Journal for Parasitology, 53(8), pp. 393-403. (doi: 10.1016/j.ijpara.2022.11.012) (PMID:36931423)

C

Challoumas, D., Zouvani, A., Creavin, K., Murray, E., Crosbie, G., Ng, N. and Millar, N. L. (2023) Determining minimal important differences for patient-reported outcome measures in shoulder, lateral elbow, patellar and Achilles tendinopathies using distribution-based methods. BMC Musculoskeletal Disorders, 24, 158. (doi: 10.1186/s12891-023-06261-9) (PMID:36864412) (PMCID:PMC9979571)

Chawla, J. et al. (2023) Phenotypic screens identify genetic factors associated with gametocyte development in the human malaria parasite Plasmodium falciparum. Microbiology Spectrum, 11(3), e0416422. (doi: 10.1128/spectrum.04164-22) (PMID:37154686) (PMCID:PMC10269797)

Chong, H. Y. et al. (2023) Cost-effectiveness of cognitive behavioural and personalised exercise interventions for reducing fatigue in inflammatory rheumatic diseases. Rheumatology, 62(12), pp. 3819-3827. (doi: 10.1093/rheumatology/kead157) (PMID:37018151)

Coates, L. C. et al. (2023) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Rheumatology, 62(1), e1-e3. (doi: 10.1093/rheumatology/keac388) (PMID:35799375)

Conrad, N., McInnes, I. B. , Mcmurray, J. J.V. and Sattar, N. (2023) Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)'s recommendations for cardiovascular risk management? Annals of the Rheumatic Diseases, 82(4), pp. 457-459. (doi: 10.1136/ard-2022-223315) (PMID:36442979)

Conrad, N. et al. (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet, 401(10391), pp. 1878-1890. (doi: 10.1016/S0140-6736(23)00457-9) (PMID:37156255)

Cunningham, M. E. , McGonigal, R. , Barrie, J. A., Campbell, C. I., Yao, D. and Willison, H. J. (2023) Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain-Barré syndrome. Journal of the Peripheral Nervous System, 28(1), pp. 17-31. (doi: 10.1111/jns.12532) (PMID:36710500)

E

Edwards, S. C. et al. (2023) PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ T cells. Journal of Experimental Medicine, 220(2), e20211431. (doi: 10.1084/jem.20211431) (PMID:36480166) (PMCID:PMC9732671)

F

Fragoulis, G. E., Vetsika, E.-K., Kyriakidi, M., Verrou, K.-M., Kollias, G., Tektonidou, M. G., McInnes, I. B. and Sfikakis, P. P. (2023) Distinct innate and adaptive immunity phenotypic profile at the circulating single-cell level in psoriatic arthritis. Clinical Immunology, 253, 109679. (doi: 10.1016/j.clim.2023.109679) (PMID:37336253)

G

Gamble, A., Suessmilch, M., Bonestroo, A., Merits, A., Graham, G. J. , Cavanagh, J. , Edgar, J. M. and Pingen, M. (2023) Establishing mixed neuronal and glial cell cultures from embryonic mouse brains to study infection and innate immunity. Journal of Visualized Experiments(196), 65331. (doi: 10.3791/65331) (PMID:37458443)

Gatt, Z., Gunes, U., Raponi, A., Camargo da Rosa, L. and Brewer, J. M. (2023) Review: Unravelling the role of DNA sensing in alum adjuvant activity. Discovery Immunology, 2(1), kyac012. (doi: 10.1093/discim/kyac012)

Gossec, L. et al. (2023) Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study. Arthritis Research and Therapy, 25, 109. (doi: 10.1186/s13075-023-03058-y) (PMID:37353788) (PMCID:PMC10288720)

Gossec, L. et al. (2023) Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study. Annals of the Rheumatic Diseases, 82(4), pp. 496-506. (doi: 10.1136/ard-2022-222879) (PMID:36600178) (PMCID:PMC10086293)

Gossec, L., Theander, E., Chakravarty, S. D., Bergmans, P., Lavie, F., Noël, W., Sharaf, M., Siebert, S. and Smolen, J. S. (2023) Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study. Arthritis Research and Therapy, 25, 100. (doi: 10.1186/s13075-023-03078-8) (PMID:37296456) (PMCID:PMC10251537)

Gottlieb, A. B. et al. (2023) Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis. RMD Open, 9(1), e002789. (doi: 10.1136/rmdopen-2022-002789) (PMID:36828643) (PMCID:PMC9972414)

Gray, A. L. et al. (2023) Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors. Cell Reports, 42(1), 111930. (doi: 10.1016/j.celrep.2022.111930) (PMID:36640356)

Gupta, L., Najm, A. , Kabir, K. and De Cock, D. (2023) Digital health in musculoskeletal care: where are we heading? BMC Musculoskeletal Disorders, 24, 192. (doi: 10.1186/s12891-023-06309-w) (PMID:36918856) (PMCID:PMC10012296)

H

Haese-Hill, W., Crouch, K. and Otto, T. D. (2023) peaks2utr: a robust Python tool for the annotation of 3’ UTRs. Bioinformatics, 39(3), btad112. (doi: 10.1093/bioinformatics/btad112) (PMID:36864613) (PMCID:PMC10008064)

Halstead, S. K. et al. (2023) Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats. Journal of the Peripheral Nervous System, 28(1), pp. 32-40. (doi: 10.1111/jns.12529) (PMID:36573790)

Hunter, C. L.C., McNeill, F. and Tripkovic, M. (2023) Criminal disenfranchisement: Developments in, and lessons from, Scotland. Howard Journal of Crime and Justice, (doi: 10.1111/hojo.12546) (Early Online Publication)

I

Iaconelli, A., Cuthbert, J., Kazmi, S., Maffia, P. , Clark, A. L., Cleland, J. G.F. and Pellicori, P. (2023) Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity. Clinical Research in Cardiology, 112(8), pp. 1077-1086. (doi: 10.1007/s00392-023-02178-4) (PMID:36894788) (PMCID:PMC10359207)

Iaconelli, A., Pellicori, P. , Caiazzo, E., Rezig, A. O. M. , Bruzzese, D., Maffia, P. and Cleland, J. G. F. (2023) Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials. Clinical Research in Cardiology, 112(8), pp. 1007-1019. (doi: 10.1007/s00392-022-02104-0) (PMID:36241896) (PMCID:PMC9568893)

Iaconelli, A. et al. (2023) Coronary revascularization for heart failure with coronary artery disease: a systematic review and meta-analysis of randomized trials. European Journal of Heart Failure, 25(7), pp. 1170-1175. (doi: 10.1002/ejhf.2911) (PMID:37211964)

J

Jaffery, H. et al. (2023) IĸB Protein BCL3 as a controller of osteogenesis and bone health. Arthritis and Rheumatology, 75(12), 2148-2160-2148-2160. (doi: 10.1002/art.42639) (PMID:37410754)

Jatkowska, A. et al. (2023) Development and validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance. Journal of Crohn's and Colitis, 17(9), pp. 1426-1435. (doi: 10.1093/ecco-jcc/jjad063) (PMID:37004165) (PMCID:PMC10588781)

Johnsson, H., Cole, J., Siebert, S. , McInnes, I. B. and Graham, G. (2023) Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways. Arthritis Research and Therapy, 25, 73. (doi: 10.1186/s13075-023-03034-6) (PMID:37131254) (PMCID:PMC10152590)

K

Kennedy, J., Kennedy, N., Cooksey, R., Choy, E., Siebert, S. , Rahman, M. and Brophy, S. (2023) Predicting a diagnosis of ankylosing spondylitis using primary care health records–a machine learning approach. PLoS ONE, 18(3), e0279076. (doi: 10.1371/journal.pone.0279076) (PMID:37000839) (PMCID:PMC10065228)

Kilonzo, K. G. et al. (2023) Estimating the prevalence, quality of life, economic and societal impact of arthritis in Tanzania: protocol for a mixed methods study [Protocol]. Other. protocols.io. (doi: 10.17504/protocols.io.8epv5j8r4l1b/v1).

L

Lindsay, S. L. , McCanney, G. A., Zhan, J., Scheld, M., Sherrard Smith, R., Goodyear, C. S. , Yates, E. A., Kipp, M., Turnbull, J. E. and Barnett, S. C. (2023) Low sulfated heparan sulfate mimetic differentially affects repair in immune-mediated and toxin-induced experimental models of demyelination. Glia, 71(7), pp. 1683-1698. (doi: 10.1002/glia.24363) (PMID:36945189)

Lindsay, S. L. , Sherrard-Smith, R., Yates, E. A., Cartwright, C., Thacker, B. E., Turnbull, J. E., Glass, C. A. and Barnett, S. C. (2023) Validation of recombinant heparan sulphate reagents for CNS repair. Biology, 12(3), 407. (doi: 10.3390/biology12030407) (PMID:36979099) (PMCID:PMC10044841)

M

Mair, C. , Brown, K., Beekman, E., Olowe, E. and Macaulay, C. (2023) Nurturing learning development through student feedback. Journal of Learning Development in Higher Education, 29, (doi: 10.47408/jldhe.vi29.1116)

Malcolm, J. et al. (2023) C-terminal citrullinated peptide alters antigen-specific APC:T cell interactions leading to breach of immune tolerance. Journal of Autoimmunity, 135, 102994. (doi: 10.1016/j.jaut.2023.102994) (PMID:36706535)

McGonigal, R. , Cunningham, M. E. , Smyth, D., Chou, M., Barrie, J. A., Wilkie, A., Campbell, C., Saatman, K. E., Lunn, M. and Willison, H. J. (2023) The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain-Barré syndrome. Journal of the Peripheral Nervous System, 28(1), pp. 4-16. (doi: 10.1111/jns.12520) (PMID:36335586)

McInnes, I. B. et al. (2023) Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL). Lancet, 401(10370), pp. 25-37. (doi: 10.1016/S0140-6736(22)02302-9) (PMID:36493791)

McInnes, I. B. et al. (2023) Efficacy and safety of upadacitinib in patients with psoriatic arthritis: 2-year results from the phase 3 SELECT-PsA 1 study. Rheumatology and Therapy, 10(1), pp. 275-292. (doi: 10.1007/s40744-022-00499-w) (PMID:36243812) (PMCID:PMC9569172)

McInnes, I. B. and Merola, J. F. (2023) Questions about the BE OPTIMAL trial - authors' reply. Lancet, 401(10392), p. 1928. (doi: 10.1016/S0140-6736(23)00969-8) (PMID:37301582)

Mease, P. J. et al. (2023) Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis. Rheumatology, 62(4), pp. 1417-1425. (doi: 10.1093/rheumatology/keac500) (PMID:36102818) (PMCID:PMC10070072)

Merola, J. F. et al. (2023) Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE). Lancet, 401(10370), pp. 38-48. (doi: 10.1016/S0140-6736(22)02303-0) (PMID:36495881)

Morton, F. R. , Jani, B. D. , Mair, F. S. , McLoone, P. , Canning, J., Macdonald, S. , McQueenie, R., Siebert, S. and Nicholl, B. I. (2023) Association between risk, duration and cause of hospitalisations in people with rheumatoid arthritis and multimorbidity in the UK Biobank and Scottish Early Rheumatoid Arthritis (SERA) cohorts: longitudinal observational study. Seminars in Arthritis and Rheumatism, 58, 152130. (doi: 10.1016/j.semarthrit.2022.152130) (PMID:36459724)

Mumuni, A. N., Krishnadas, R. and Cavanagh, J. (2023) Peripheral inflammation is associated with alterations in brain biochemistry and mood: evidence from in vivo proton magnetic resonance spectroscopy study. Pure and Applied Chemistry, 95(3), pp. 289-300. (doi: 10.1515/pac-2022-1119)

N

Najm, A. (2023) Comment intégrer la santé numérique dans la prise en charge de patients atteints de rhumatismes inflammatoires? = Digital health in rheumatology: where do we stand? How much further do we need to go? Revue du Rhumatisme, 90(4), pp. 476-480. (doi: 10.1016/j.rhum.2023.03.004)

Najm, A. , Alunno, A. and Machado, P. (2023) COVID - how will it continue to change our lives? Joint Bone Spine, 90(4), 105572. (doi: 10.1016/j.jbspin.2023.105572) (PMID:37028643) (PMCID:PMC10126740)

Najm, A. , Goodyear, C. S. , McInnes, I. B. and Siebert, S. (2023) Phenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy. Nature Reviews Rheumatology, 19, pp. 153-165. (doi: 10.1038/s41584-022-00874-5) (PMID:36596924)

Nyirenda, M. H., Nijjar, J. S., Frleta-Gilchrist, M., Gilchrist, D. S., Porter, D., Siebert, S. , Goodyear, C. S. and McInnes, I. B. (2023) JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation. RMD Open, 9(1), e002671. (doi: 10.1136/rmdopen-2022-002671) (PMID:36599629) (PMCID:PMC9815080)

O

O’Brien, C. M. et al. (2023) Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study. Rheumatology International, 43(8), pp. 1459-1465. (doi: 10.1007/s00296-023-05342-1) (PMID:37227468) (PMCID:PMC10261182)

P

Pærregaard, S. I. et al. (2023) The small and large intestine contain related mesenchymal subsets that derive from embryonic Gli1+ precursors. Nature Communications, 14, 2307. (doi: 10.1038/s41467-023-37952-5) (PMID:37085516) (PMCID:PMC10121680)

Pires, C. V. et al. (2023) Chemogenomic profiling of a Plasmodium falciparum transposon mutant library reveals shared effects of dihydroartemisinin and bortezomib on lipid metabolism and exported proteins. Microbiology Spectrum, 11(3), (doi: 10.1128/spectrum.05014-22) (PMID:37067430) (PMCID:PMC10269874)

R

Rahman, P. et al. (2023) Safety of guselkumab with and without prior TNF-α inhibitor treatment: pooled results across four studies in patients with psoriatic arthritis. Journal of Rheumatology, 50(6), pp. 769-780. (doi: 10.3899/jrheum.220928) (PMID:36642439)

Riedlova, P. , Sood, S., Goodyear, C. S. and Ansalone, C. (2023) Differentiation of functional osteoclasts from human peripheral blood CD14+ monocytes. Journal of Visualized Experiments(191), e64698. (doi: 10.3791/64698) (PMID:36779608)

Robb, C. T. et al. (2023) Metabolic regulation by prostaglandin E2 impairs lung group 2 innate lymphoid cell responses. Allergy, 78(3), pp. 714-730. (doi: 10.1111/all.15541) (PMID:36181709)

S

Sattar, N. , McMurray, J. J. V. , McInnes, I. B. , Aroda, V. R. and Lean, M. E. J. (2023) Treating chronic diseases without tackling excess adiposity promotes multimorbidity. Lancet Diabetes and Endocrinology, 11(1), pp. 58-62. (doi: 10.1016/S2213-8587(22)00317-5) (PMID:36460014)

Schäffner, E. et al. (2023) Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. Nature Neuroscience, 26(7), pp. 1218-1228. (doi: 10.1038/s41593-023-01366-9) (PMID:37386131)

Sforzini, L. et al. (2023) Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study. Translational Psychiatry, 13, 185. (doi: 10.1038/s41398-023-02438-x) (PMID:37264010) (PMCID:PMC10235092)

Shin, H. and An, Y. (2023) How agent-based models offer insights on strategies to mitigate soil degradation in North Korea: A conversation with Dr. Yoosoon An. Review of Artificial Societies and Social Simulation,

Siebert, S. , Behrens, F., Lubrano, E., Martin, N., Sharaf, M., Contré, C., Theander, E., Queiro, R., Zimmermann, M. and Gossec, L. (2023) PsABIOnd study and eDaily substudy design: long-term effectiveness and safety of guselkumab and IL-17 inhibitors in routine clinical practice in patients with psoriatic arthritis. Rheumatology and Therapy, 10(2), pp. 489-505. (doi: 10.1007/s40744-022-00518-w) (PMID:36585602)

Siebert, S. and Marzo-Ortega, H. (2023) Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé. Annals of the Rheumatic Diseases, 82(8), e185. (doi: 10.1136/annrheumdis-2021-221799) (PMID:34844925)

Simmons, C. et al. (2023) A novel Modulator of Ring Stage Translation (MRST) gene alters artemisinin sensitivity in Plasmodium falciparum. mSphere, 8(4), (doi: 10.1128/msphere.00152-23) (PMID:37219373) (PMCID:PMC10449512)

Simmons, C. F. et al. (2023) Protein KIC5 is a novel regulator of artemisinin stress response in the malaria parasite Plasmodium falciparum. Scientific Reports, 13, 399. (doi: 10.1038/s41598-023-27417-6) (PMID:36624300) (PMCID:PMC9829687)

Sinclair, M. , Sermpezi, R., Zhao, Q. , Mitchell, R. and Bailey, N. (2023) Estimating Greenspace Visitation Using Digital Footprints Data: A Collaboration with Glasgow City Council to Aid in Open Space Policy and Operations [poster]. In: 12th International Conference on Geographic Information Science (GIScience 2023), Leeds, UK, 14-19 Sept 2023, (Accepted for Publication)

Smolen, J. S. et al. (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), pp. 3-18. (doi: 10.1136/ard-2022-223356) (PMID:36357155)

Smyth, D. J. , White, M. P.J., Johnston, C. J.C., Donachie, A.-M., Campillo Poveda, M. , McSorley, H. J. and Maizels, R. M. (2023) Protection from T cell-dependent colitis by the helminth-derived immunomodulatory mimic of transforming growth factor-ß, Hp-TGM. Discovery Immunology, 2(1), kyad001. (doi: 10.1093/discim/kyad001) (PMID:36855464) (PMCID:PMC9958376)

Sophocleous, A., Azfer, A., Huesa, C., Stylianou, E. and Ralston, S. H. (2023) Probiotics inhibit cartilage damage and progression of osteoarthritis in mice. Calcified Tissue International, 112(1), pp. 66-73. (doi: 10.1007/s00223-022-01030-7) (PMID:36261653) (PMCID:PMC9813193)

Steyer, A. M. et al. (2023) Focused ion beam-scanning electron microscopy links pathological myelin outfoldings to axonal changes in mice lacking Plp1 or Mag. Glia, 71(3), pp. 509-523. (doi: 10.1002/glia.24290) (PMID:36354016)

Sunzini, F., Schrepf, A., Clauw, D. J. and Basu, N. (2023) The biology of pain: through the rheumatology lens. Arthritis and Rheumatology, 75(5), pp. 650-660. (doi: 10.1002/art.42429) (PMID:36599071)

V

Van Kuijk, A. W.R. et al. (2023) Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data. Rheumatology, 62(10), pp. 3382-3390. (doi: 10.1093/rheumatology/kead089) (PMID:36810788) (PMCID:PMC10547514)

W

Ward, E. J. et al. (2023) Placental inflammation leads to abnormal embryonic heart development. Circulation, 147(12), pp. 956-972. (doi: 10.1161/CIRCULATIONAHA.122.061934) (PMID:36484244) (PMCID:PMC10022676)

Wasker, S. V. Z., Challoumas, D., Weng, W., Murrell, G. A.C. and Millar, N. L. (2023) Is neurogenic inflammation involved in tendinopathy? A systematic review. BMJ Open Sport and Exercise Medicine, 9(1), e001494. (doi: 10.1136/bmjsem-2022-001494) (PMID:36793930) (PMCID:PMC9923261)

Westerhof, L. M., Noonan, J., Hargrave, K. E., Chimbayo, E. T., Cheng, Z., Purnell, T., Jackson, M. R. , Borcherding, N. and MacLeod, M. K.L. (2023) Multifunctional cytokine production marks influenza A virus specific CD4 T cells with high expression of survival molecules. European Journal of Immunology, 53(11), 2350559. (doi: 10.1002/eji.202350559) (PMID:37490492)

Winthrop, K. L. et al. (2023) Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the Rheumatic Diseases, 82(5), pp. 594-598. (doi: 10.1136/ard-2022-223528) (PMID:36702529)

Z

Zhao, S. S. et al. (2023) Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 7(2), rkad039. (doi: 10.1093/rap/rkad039) (PMID:37197377) (PMCID:PMC10183299)

This list was generated on Thu Mar 28 07:14:39 2024 GMT.